Advertisement
Written by the OrganizedWisdom Team with as the reviewer. All original content is supervised by the The OrganizedWisdom Medical Review Team
smalltimes.com
1 of 0
Wall Street may be skeptical about nanotech companies without proven products or revenues going public, but NUCRYST Pharmaceuticals is making money today on its silver nanoparticle dressings for burns and chronic wounds. Profitable since 2001, Nucryst is a subsidiary of a Canadian company, the Westaim Corporation, which has $85 million in cash, no debt and may be a nanotech pure play that even a financial conservative could appreciate.
Advertisement
This site complies with the HONcode standard for trustworthy health information: verify here.
© 2012 OrganizedWisdom.com, Inc. All rights reserved.
OrganizedWisdom does not provide medical advice, diagnosis or treatment. If you think you
may have a medical emergency, call your doctor or 911 immediately.
As Seen In
